Sollievo Pharmaceuticals

When Minutes Matter

Print
Claim My Business View on StartEngine
Security Type
Common Stock
Categories
Pharmaceutical
Min Investment
$400
Location
San Juan Capistrano, CA
Expected Close Date
November 16, 2022
Amount Raised
$15,897
Target Raise
$10K-$1M
No. Investors
14
Security Price
$2
Valuation
$20,000,000
Number of Employees
1
Cash
$153
Revenue
$0
Short Term Debt
$772,225
Cost of Goods
$0
Long Term Debt
$1,252,890
Net Income
$-189,478

Company Description

Sollievo Pharmaceuticals is seeking to improve safety for healthcare staff with our first product, Proviza. Proviza is a fast-acting sedative developed to address the rising incidence of injuries and abuse to healthcare staff when treating agitated and aggressive patients. Sollievo Pharmaceuticals is pre-revenue and in the development and scale-up stages.

Perks

StartEngine OWNERS Exclusive Click here to learn more

$200+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

Super Early Bird Bonus
Invest within the first four weeks and receive 20% bonus shares.




27
days

14
hours

14
mins

19
secs

$500+ Investment
Company Bonus
Invest $500+ and receive 5% bonus shares.

$1,000+ Investment
Silver Bonus
Invest $1,000+ and receive 10% bonus shares.

$5,000+ Investment
Gold Bonus
Invest $5,000+ and receive 15% bonus shares.

$10,000+ Investment
Platinum Bonus
Invest $10,000+ and receive 20% bonus shares

Key Deal Facts

7 out of 10 emergency physicians say emergency department violence is increasing and half have been physically assaulted at work. Proviza was developed to address this public health crisis.*
We believe Sollievo has the potential of disrupting the estimated $1.2B global intramuscular agitation and aggression treatment market by introducing one of the fastest acting intramuscular solutions compared to competitors on the market today.**
Sollievo's leadership and consulting team represents more than 100 years of combined experience in the pharmaceutical and medical industries.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments